These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 30726758)
1. A Dozen Years of Discovery: Insights into the Physiology and Pharmacology of FGF21. Kliewer SA; Mangelsdorf DJ Cell Metab; 2019 Feb; 29(2):246-253. PubMed ID: 30726758 [TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 21: from pharmacology to physiology. Kliewer SA; Mangelsdorf DJ Am J Clin Nutr; 2010 Jan; 91(1):254S-257S. PubMed ID: 19906798 [TBL] [Abstract][Full Text] [Related]
4. FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys. Andersen B; Straarup EM; Heppner KM; Takahashi DL; Raffaele V; Dissen GA; Lewandowski K; Bödvarsdottir TB; Raun K; Grove KL; Kievit P Int J Obes (Lond); 2018 Jun; 42(6):1151-1160. PubMed ID: 29892039 [TBL] [Abstract][Full Text] [Related]
5. Multiple roles of fibroblast growth factor 21 in metabolism. Li LI; Tang L Curr Pharm Des; 2015; 21(21):3041-50. PubMed ID: 25675147 [TBL] [Abstract][Full Text] [Related]
6. [THE ROLE OF FIBROBLAST GROWTH FACTOR 21 (FGF21) IN THE REGULATION AND CORRECTION OF CARBOHYDRATE AND LIPID METABOLISM]. Marakova EN; Bazhan NM Ross Fiziol Zh Im I M Sechenova; 2016 Dec; 102(12):1406-16. PubMed ID: 30198244 [TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21: a novel metabolic regulator from pharmacology to physiology. Li H; Zhang J; Jia W Front Med; 2013 Mar; 7(1):25-30. PubMed ID: 23358894 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice. Weng Y; Chabot JR; Bernardo B; Yan Q; Zhu Y; Brenner MB; Vage C; Logan A; Calle R; Talukdar S PLoS One; 2015; 10(3):e0119104. PubMed ID: 25790234 [TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological FGF21 signals to glutamatergic neurons to enhance leptin action and lower body weight during obesity. Claflin KE; Sullivan AI; Naber MC; Flippo KH; Morgan DA; Neff TJ; Jensen-Cody SO; Zhu Z; Zingman LV; Rahmouni K; Potthoff MJ Mol Metab; 2022 Oct; 64():101564. PubMed ID: 35944896 [TBL] [Abstract][Full Text] [Related]
11. FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia. Lan T; Morgan DA; Rahmouni K; Sonoda J; Fu X; Burgess SC; Holland WL; Kliewer SA; Mangelsdorf DJ Cell Metab; 2017 Nov; 26(5):709-718.e3. PubMed ID: 28988823 [TBL] [Abstract][Full Text] [Related]
12. FGF21 decreases food intake and body weight in obese Göttingen minipigs. Christoffersen B; Straarup EM; Lykkegaard K; Fels JJ; Sass-Ørum K; Zhang X; Raun K; Andersen B Diabetes Obes Metab; 2019 Mar; 21(3):592-600. PubMed ID: 30328263 [TBL] [Abstract][Full Text] [Related]
13. Physiology and Endocrinology Symposium: FGF21: Insights into mechanism of action from preclinical studies. Antonellis PJ; Kharitonenkov A; Adams AC J Anim Sci; 2014 Feb; 92(2):407-13. PubMed ID: 24398833 [TBL] [Abstract][Full Text] [Related]